Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![MarketRebels Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::817007725666242561.png) Market Rebellion [@MarketRebels](/creator/twitter/MarketRebels) on x 346.5K followers
Created: 2025-06-04 19:36:00 UTC

Zai Lab Ltd $ZLAB jumps after announcing updated data from a global Phase 1a/1b trial for zocilurtatug pelitecan, a potential first-in-class DLL3 ADC for extensive-stage SCLC, to be presented at ASCO 2025. Experts highlight urgent need for new therapies. #ITSNOTANOPTION @jonnajarian @petenajarian

![](https://pbs.twimg.com/amplify_video_thumb/1930332999515504640/img/kaAHAT84mKNXfJs0.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1930347825516425369/c:line.svg)

**Related Topics**
[$zlab](/topic/$zlab)
[$9688hk](/topic/$9688hk)

[Post Link](https://x.com/MarketRebels/status/1930347825516425369)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

MarketRebels Avatar Market Rebellion @MarketRebels on x 346.5K followers Created: 2025-06-04 19:36:00 UTC

Zai Lab Ltd $ZLAB jumps after announcing updated data from a global Phase 1a/1b trial for zocilurtatug pelitecan, a potential first-in-class DLL3 ADC for extensive-stage SCLC, to be presented at ASCO 2025. Experts highlight urgent need for new therapies. #ITSNOTANOPTION @jonnajarian @petenajarian

XXXXX engagements

Engagements Line Chart

Related Topics $zlab $9688hk

Post Link

post/tweet::1930347825516425369
/post/tweet::1930347825516425369